Venovenous extracorporeal membrane oxygenation (VV-ECMO) may be a lifesaving rescue therapy for patients with severe coronavirus disease 2019 (COVID-19). However, little is known regarding the efficacy of prolonged ECMO (duration longer than 14 days) in patients with COVID-19. In this case report, we report the successful use of prolonged VV-ECMO (111 days) in a 61-year-old man with severe COVID-19. Given the high mortality rate of severe COVID-19, this case provided evidence for use of prolonged VV-ECMO as supportive care in patients with severe COVID-19.
All Keywords
【저자키워드】 COVID-19, Acute respiratory failure, extracorporeal membrane oxygenation, acute respiratory disease syndrome, prolonged maintenance, 【초록키워드】 Efficacy, therapy, severe COVID-19, VV-ECMO, Case report, Patient, ECMO, Evidence, supportive care, severe coronavirus disease, high mortality rate, provided, patients with COVID-19, 【제목키워드】 VV-ECMO, Prolonged,
【저자키워드】 COVID-19, Acute respiratory failure, extracorporeal membrane oxygenation, acute respiratory disease syndrome, prolonged maintenance, 【초록키워드】 Efficacy, therapy, severe COVID-19, VV-ECMO, Case report, Patient, ECMO, Evidence, supportive care, severe coronavirus disease, high mortality rate, provided, patients with COVID-19, 【제목키워드】 VV-ECMO, Prolonged,